*By Amanda Weston* The twins Josh and Jonathan Baker's evident passion helped them land established stars and newcomers with big potential for their first major film project. The film ["Kin"](https://www.youtube.com/watch?v=Ac5wrM2uYbk) is marketed as "a pulse-pounding crime thriller with a sci-fi twist," that tells the story of two brothers on the run from criminals and "otherworldly soldiers" armed with a mysterious weapon. The cast includes Hollywood veterans Dennis Quaid, James Franco, and Zoë Kravitz, and the young actor Myles Truitt in his first feature film role. "If you've got something cool, people want to work on something cool," Josh said an interview Friday on Cheddar. "So I think we had something that felt a little fresh and a little different, and it was amazing that you put it in front of these people and they are interested." The co-directors said the film was a collaborative process ー with each other and the actors. Though they didn't have as much feature-film experience as their cast, the brothers had no problem giving direction. "I'd also say the more professional the actor is, the more they're kind of like 'look, just tell me what you guys want and we'll figure it out together,'" said Josh. "So someone like Dennis? Easy to work with." Finding new faces was a process. For one of the main characters of the film, Eli, producers considered about 200 young actors before casting Truitt. He had an emotional maturity that is hard to find in child actors, Josh said, adding they were "lucky" to find him. "He had a real subtlety about him, and a lot of it is observed through his eyes without dialogue, which he was great at," said Jonathan. As streaming platforms like Amazon Prime Video and Netflix become more popular destinations for features than movie screens, Jonathan said he was honored their film would play in a cinema. "Kin" will be in theaters Aug. 31, including some IMAX theaters. Josh said he felt lucky "Kin" would get a theatrical release because so many small and medium films are being phased out of theaters for big-budget blockbuster fare. "This is built for people that love sophisticated, character-driven storytelling," said Jonathan. "This is a sci-fi, but it's also a lot of other things. There's a real intimacy to that. It's not a giant blockbuster. I think people that are dying for something a little more unique, a little different, will love this." For full interview, [click here] (https://cms.cheddar.com/videos/VmlkZW8tMjIyNjM=).

Share:
More In Culture
RapidAPI Raises $150 Million to Empower Developers to Innovate and Build Software Faster with APIs
API platform RapidAPI recently became a unicorn with a $1 billion valuation after raising $150 million in a Series D funding round led by Softbank Vision Two Fund. Microsoft's Venture Fund, M12, and Andreessen Horowitz also participated. RapidAPI says it provides the world's largest API hub which enables millions of developers and companies to build software faster. Iddo Gino, founder and CEO of RapidAPI, joins Cheddar News' Closing Bell to discuss.
Want to Get in on Long Distance Dating? Bumble's Shan Boodram Has Tips
In a recent Bumble survey, more than a third of respondents revealed that they would be willing to date people in other cities. Shan Boodram, a sex and relationships expert for the app, joined Cheddar News to talk about the long-distance dating trend and tips on how to go about taking part. "I think this is the magic of what we experienced over the past couple of years, is that we have already learned the tools necessary to stay connected with people despite not being able to be close to them," she noted. Boodram also pointed to Bumble's travel mode and using video conferencing in order to ease into such relationships.
Siponey Reimagines the Canned Cocktail Space
Amanda Victoria, co-founder and CEO of Siponey, joins Cheddar News to talk about the company's canned cocktails. The spritz is made with only four ingredients — wildflower honey, aged rye whiskey, sparkling water, and fresh lemon juice.
A New Plant-Based Way to Quit Smoking
John Bencich, CEO of Achieve Life Sciences, joins Cheddar Innovates to discuss a new plant-based compound that's being used to fight nicotine addiction.
Plant-Based Way to Quit Smoking; Innovation in Stroke Therapy
On this episode of Cheddar Innovates: CEO of Achieve Life Sciences discusses a new plant-based compound that's being used to fight nicotine addiction; President & CEO OF DiaMedica Therapeutics explains a new ischemic stroke treatment option that expands the window for effective therapy for stroke patients; Cheddar gets a look at Curiosity Stream's 'Asteroid Rush.'
Load More